Parkinson's disease: a breakthrough thanks to gene therapy
- Details
- Created on Friday, 10 January 2014 09:26
Parkinson's disease: a breakthrough thanks to gene therapy
A Franco-British team (AP-HP, INSERM, UPEC, CEA / MIRCen, Oxford Biomedica, Cambridge University) conducted a Phase I-II gene therapy clinical trial in patients with an advanced form of Parkinson’s disease.
MIRCen acquired a new Magnetic resonance imaging (MRI) scanner (11,7 Teslas) dedicated to rodents
- Details
- Created on Tuesday, 01 October 2013 09:22
MIRCen, preclinical research platform on neurodegenerative diseases located in Fontenay-aux-Roses, has just acquired a new Magnetic resonance imaging (MRI) scanner dedicated to rodents.
Kick off Meeting de NeurATRIS (2)
- Details
- Created on Friday, 24 May 2013 00:00
Kick off Meeting de NeurATRIS, Infrastructure de Recherche Translationnelle pour les Biothérapies en Neurosciences
Kick off Meeting de NeurATRIS
- Details
- Created on Friday, 24 May 2013 00:00
Kick off Meeting de NeurATRIS
